| Dr Barbara Jean Guillette, MD | |
|
3520 Post Rd, Warwick, RI 02886-7140 | |
| (401) 921-5800 | |
| (401) 921-5826 |
| Full Name | Dr Barbara Jean Guillette |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 39 Years |
| Location | 3520 Post Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871656611 | NPI | - | NPPES |
| 1000210 | Other | RI | UNITED HEALTHPLAN |
| 27529 | Other | RI | NEIGHBORHOOD HEALTH PLAN |
| 007726 | Other | RI | TUFTS |
| BG28625 | Medicaid | RI | |
| 004209 | Other | RI | BLUECHIP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD07726 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent And Allergy Inc | 5991768699 | 8 |
News Archive
An innovative diabetes management concept including structured self-monitoring of blood glucose (SMBG), data visualization, pattern analysis and derived therapy adjustments can significantly reduce HbA1c values, improve glycemic control and enhance patients' quality of life. These are the key findings of the 12-month data from the Structured Testing Protocol (STeP) Study, newly published in Diabetes Care.
Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.
Researchers at The Seaver Autism Center for Research and Treatment at Mount Sinai have generated and characterized a genetically modified rat model of autism and intellectual disability, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published January 31 in the journal eLife.
A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer. Researchers serendipitously discovered the beta blocker's cancer-fighting properties after making an error in the lab.
A Cancer Genomics Browser developed by researchers at the University of California, Santa Cruz, provides a new way to visualize and analyze data from studies aimed at improving cancer treatment by unraveling the complex genetic roots of the disease.
› Verified 8 days ago
| Entity Name | Ent And Allergy Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619024130 PECOS PAC ID: 5991768699 Enrollment ID: O20041104000192 |
News Archive
An innovative diabetes management concept including structured self-monitoring of blood glucose (SMBG), data visualization, pattern analysis and derived therapy adjustments can significantly reduce HbA1c values, improve glycemic control and enhance patients' quality of life. These are the key findings of the 12-month data from the Structured Testing Protocol (STeP) Study, newly published in Diabetes Care.
Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.
Researchers at The Seaver Autism Center for Research and Treatment at Mount Sinai have generated and characterized a genetically modified rat model of autism and intellectual disability, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published January 31 in the journal eLife.
A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer. Researchers serendipitously discovered the beta blocker's cancer-fighting properties after making an error in the lab.
A Cancer Genomics Browser developed by researchers at the University of California, Santa Cruz, provides a new way to visualize and analyze data from studies aimed at improving cancer treatment by unraveling the complex genetic roots of the disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Jean Guillette, MD 3520 Post Rd, Warwick, RI 02886-7140 Ph: (401) 921-5800 | Dr Barbara Jean Guillette, MD 3520 Post Rd, Warwick, RI 02886-7140 Ph: (401) 921-5800 |
News Archive
An innovative diabetes management concept including structured self-monitoring of blood glucose (SMBG), data visualization, pattern analysis and derived therapy adjustments can significantly reduce HbA1c values, improve glycemic control and enhance patients' quality of life. These are the key findings of the 12-month data from the Structured Testing Protocol (STeP) Study, newly published in Diabetes Care.
Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.
Researchers at The Seaver Autism Center for Research and Treatment at Mount Sinai have generated and characterized a genetically modified rat model of autism and intellectual disability, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published January 31 in the journal eLife.
A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer. Researchers serendipitously discovered the beta blocker's cancer-fighting properties after making an error in the lab.
A Cancer Genomics Browser developed by researchers at the University of California, Santa Cruz, provides a new way to visualize and analyze data from studies aimed at improving cancer treatment by unraveling the complex genetic roots of the disease.
› Verified 8 days ago
Robert Michael Risica, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800 Fax: 401-921-5826 | |
Dr. Charles Sidney Faber, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800 | |
Dr. Alejandro Vazquez, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800 Fax: 401-921-5826 | |
Dr. Mark Peter Andreozzi, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800 Fax: 401-921-5826 | |
Dr. Amit Patel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800 Fax: 401-921-5826 | |
George J. Jacewicz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 95 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-6111 Fax: 401-732-0155 |